Harvest Technologies Corp.
This article was originally published in Start Up
Executive Summary
Harvest is building upon the autotransfusion concept to create devices which not only have the capacity to collect a patient's blood just prior to and during surgery, but which can also convert collected blood into autologous blood products that promote post-surgical wound healing, bone growth and hemostasis.
You may also be interested in...
Harvest Steps into Stem Cells
Harvest Technologies, a 14-year-old player in the blood and marrow supply arena, is moving aggressively into the business of selling stem cells therapies for cardiovascular disease.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.